Overview
Soon Lim practices in Singapore, Singapore. Lim is rated as a Distinguished expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Their top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, and B-Cell Lymphoma.
Their clinical research consists of co-authoring 142 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 19 articles in the study of Peripheral T-Cell Lymphoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Angioimmunoblastic T-cell Lymphoma
- B-Cell LymphomaLim isDistinguished. Learn about B-Cell Lymphoma.
- Non-Hodgkin LymphomaLim isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Peripheral T-Cell LymphomaLim isDistinguished. Learn about Peripheral T-Cell Lymphoma.
- T-Cell LymphomaLim isDistinguished. Learn about T-Cell Lymphoma.
- Advanced
- AgranulocytosisLim isAdvanced. Learn about Agranulocytosis.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Lymphofollicular Hyperplasia
- MononucleosisLim isAdvanced. Learn about Mononucleosis.
- Experienced
- Anaplastic Large Cell Lymphoma
- AthetosisLim isExperienced. Learn about Athetosis.
- Burkitt LymphomaLim isExperienced. Learn about Burkitt Lymphoma.
- Castleman DiseaseLim isExperienced. Learn about Castleman Disease.
- Classical Hodgkin Lymphoma
- COVID-19Lim isExperienced. Learn about COVID-19.